share_log

HC Wainwright & Co. Reiterates Buy on Leap Therapeutics, Maintains $7 Price Target

HC Wainwright & Co. Reiterates Buy on Leap Therapeutics, Maintains $7 Price Target

HC Wainwright & Co.重申買入Leap Therapeutics,維持7美元的目標股價
Moomoo 24/7 ·  03/19 06:48

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Leap Therapeutics (NASDAQ:LPTX) with a Buy and maintains $7 price target.

HC Wainwright & Co. 分析師Swayampakula Ramakanth重申Leap Therapeutics(納斯達克股票代碼:LPTX)的買入並維持7美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論